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Abstract
Introduction Aberrant microenvironment and endoplasmic
reticulum (ER) stress are associated with solid-tumor
progression. Stress proteins, like heat shock proteins and
glucose-regulated proteins, are frequently overexpressed in
human tumors. It has been reported that derlin-1 is involved in
ER stress response. In vitro studies have demonstrated that
derlin-1 participates in the retrotranslocation of misfolded
proteins from ER into the cytosol. Because the roles of derlin-1
in human cancer have not yet been characterized, we
investigated the expression of derlin-1 in human breast
carcinoma and whether it protected cancer cells against ER
stress-induced apoptosis.
Methods Surgical specimens of human breast cancer and/or
paired normal tissues from the same patients were collected for
immunohistochemical and/or Western blot analysis with anti-
human derlin-1 antibody. The expression of derlin-1 in human
breast cancer cell lines was detected by reverse transcription-
polymerase chain reaction or Western blot. A synthetic small
interfering RNA against derlin-1 was introduced into breast
cancer cells to inhibit derlin-1 expression. The effects of derlin-
1 knockdown on ER stress-induced apoptosis were determined
by flow cytometry analysis.
Results These analyses demonstrated that 66.7% of the breast
carcinoma tissues expressed derlin-1, whereas derlin-1 was
rarely expressed in normal mammary glands. The expression of
derlin-1 in human breast carcinoma correlated with tumor grade
and axillary lymph node metastasis. On examining the
expression of derlin-1 in human breast cancer cell lines, we
found that derlin-1 expression was enhanced by ER stress-
inducing agents. Derlin-1 knockdown sensitized breast cancer
cells to ER stress-induced apoptosis.
Conclusion The observed derlin-1 overexpression in breast
cancer, together with its function in relieving ER stress-induced
apoptosis, suggests that regulation of the ER stress response
pathway may be critical in the development and progression of
breast cancer.
Introduction
Neoplastic progression requires several genetic alterations
that allow cells to escape from growth control and disable
apoptotic signaling [1]. During tumor development and pro-
gression, cancer cells encounter variations in their environ-
ment which cause cytotoxic stress and adversely affect cell
survival [2]. Eukaryotic cells express various proteins that can
protect cells against these cytotoxic stresses that arise in the
intra- and extra-cellular microenvironments. A variety of cyto-
toxic conditions, like hypoxia, nutrient starvation, and pH
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changes, are frequently encountered by poorly vascularized
solid-tumor cells and can become growth-limiting [3,4]. These
conditions evoke a range of cellular stress-responsive path-
ways, including cytoprotective or cytodestructive branches.
The cellular viability during limited nutrient and oxygen condi-
tions depends on where the balance between cytoprotective
and cytodestructive branches lies in tumor development.
Hypoxia and nutrient deprivation may induce endoplasmic
reticulum (ER) stress and activate the unfolded protein
response (UPR), which is an adaptive response that contrib-
utes to increased survival under ER stress conditions [5,6]. ER
is the first compartment of the secretory pathway and is a
processing station for secreted and transmembrane proteins.
The primary function of ER is to assist newly synthesized pro-
teins to refold into native conformation. To achieve correct
folding and maturation, secreted proteins must translocate
into the ER to undergo several post-translational modifica-
tions, including glycosylation and disulfide binding [7]. The
quality of proteins in the ER is tightly controlled by resident ER
chaperone and folding enzymes [8]. Proteins that do not
mature properly are retrotranslocated to the cytosol for degra-
dation by the 26S proteasome [9]. The ER-associated degra-
dation (ERAD) machinery serves as one part of the adaptive
cellular program to destroy the potentially toxic accumulation
of misfolded proteins. Upon ER stress, different branches
within the UPR may be activated or enhanced to meet the ele-
vated demand and to maintain cellular homeostasis [10].
Although the primary function of the UPR is to protect cells
against ER stress, prolonged or unalleviated ER stress may
eventually activate multiple apoptotic pathways resulting in
cell death [11].
Studies have established a role for UPR in cancer progression.
UPR is activated in various types of tumors, cell lines, and
tumor models. GRP78, an ER chaperone, also referred to as
BiP, serves as a hallmark of UPR [12]. GRP78 was more fre-
quently overexpressed in the higher-grade tumors, indicating
that activation of the UPR may correlate with a clinically more
aggressive phenotype [13]. This is in keeping with a recent
study reporting that elevated GRP78 expression correlates
with lymph node metastasis and poor prognosis in patients
with gastric cancer [14]. Given the importance of UPR in
tumor progression and the potential role of UPR markers in
both prognosis and treatment of malignant tumors, we investi-
gated the expression of other molecules that are involved in
ER stress response in breast cancer. In addition to molecular
chaperones, the retrotranslocation machinery plays essential
roles in a multi-step process (ERAD), which is dedicated to
degrading the misfolded proteins or unassembled protein
complexes [15]. One of the best-characterized components of
the retrotranslocation machinery is the cytosolic ATPase p97/
Valosin-containing protein (VCP) [16]. Some evidence sug-
gests that p97 expression correlates with tumor recurrence
and metastasis [17]. Recently, a partner of the p97 ATPase
complex, derlin-1, was identified. Derlin-1 reportedly mediates
retrotranslocation of misfolded proteins from ER lumen into
the cytosol [18,19]. Little is known about the expression of
derlin-1 in tumors and the regulation of derlin-1 in tumor cells.
In this study, we detected the expression of derlin-1 in breast
tumors and investigated its function in relieving ER stress-
induced apoptosis, in order to better understand its role in
tumor biology and its potential implication for cancer
progression.
Materials and methods
Tissues
TissuesAll tumor specimens were collected from patients who
underwent breast lumpectomies or mastectomies. Sections of
formalin-fixed paraffin-embedded breast tumors from 42
patients who were treated at West China Hospital (Sichuan
University, Chengdu, China) from 2005 to 2007 were
obtained for immuohistochemical analysis. In addition, grossly
dissected pieces of tumor and paired normal breast tissues
from 13 of the 42 cases were stored at -80°C until Western
blot analysis. Consent for use of tissue specimens was
obtained from the West China Hospital Institutional Review
Board and patients. The diagnosis of each tumor was obtained
from pathologic examination of tissue sections.
Reagents
Tunicamycin (TM), thapsigargin (TG), and staurosporine were
purchased from Sigma-Aldrich (St. Louis, MO, USA) and dis-
solved in Me2SO at concentrations of 2 mg/mL, 0.3 mM, and
1 mM, respectively, for storage. All of them were stored at -
20°C. To induce ER stress, cells were treated with 2 μg/mL
TM and 300 nM TG for 24 hours.
Cell lines and cell culture
All human breast cancer cell lines (MDA-MB-435, MDA-MB-
453, MCF-7, SKBR-3, 1590, and T47D) were grown in Dul-
becco's minimal essential medium containing 10% fetal
bovine serum and 50 units/mL penicillin and 50 μg/mL strep-
tomycin sulfate. Cells were incubated at 37°C in a humidified
atmosphere of 5% CO2. Cells were plated 24 hours before
TM or TG was added to the fresh medium.
Polyclonal antibodies
Anti-derlin-1 antisera was generated by immunizing rabbits
with peptides coupled to keyhole-limpet hemocyanin through
an added cysteine residue. The derlin-1 sequence used was
(C)RHNWGQGFRLGDQ. The titer for anti-derlin-1 antisera
was more than 1 × 109. Antibodies specific to the C-terminus
of human derlin-1 were affinity-purified with Sepharose 4B,
which was conjugated with the C-terminus peptide of derlin-1.
The polyclonal antibody, like the others, is affinity-purified and
is specific for human derlin-1, recognizing a single 28-kDa
band on Western blot. The affinity-purified anti-derlin-1 poly-
clonal antibody was used for immunohistochemical and West-Available online http://breast-cancer-research.com/content/10/1/R7
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ern blot analysis. Anti-GRP78 antibody was purchased from
Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).
Immunohistochemistry
Immunohistochemistry (IHC) was performed on tissue sec-
tions from formalin-fixed paraffin-embedded tissue blocks of
the patients in the study. Tissue sections were mounted on
slides and deparaffinized by 2 × 10-minute incubations in
xylene followed by 2 × 10-minute dips in 100% ethanol, 2 ×
10-minute dips in 95% ethanol, a 5-minute incubation in 3%
hydrogen peroxide, and water rinse. The slides were subjected
to antigen retrieval. These slides were immersed once in 10%
citrate buffer and boiled at 90°C for 15 minutes and then left
in the heated solution for an additional 20 minutes. All slides
were then soaked for a minimum of 5 minutes in phosphate-
buffered saline (PBS), followed by incubation with normal
immunoglobulin G (IgG) for 15 minutes and anti-derlin-1 anti-
body or control IgG for 2 hours at room temperature. The
slides were then rinsed with PBS three times and incubated
with biotin-labeled goat anti-rabbit IgG for 15 minutes. After
being washed in PBS three times, the slides were incubated
with streptavidin/horseradish peroxidase (HRP) for 15 min-
utes, stained with diaminobenzidine chromagen, and counter-
stained with hematoxylin. Slides were then dehydrated in
graded ethanols and xylene and coverslipped. Slides were vis-
ualized with light microscopy and qualitatively scored while
investigators were blinded to clinicalpathological variables. An
immunohistochemical grading scale for derlin-1 expression
was empirically determined ranging from (0) none to (1) weak
(negative) or from (2) moderate to (3) strong (positive). In addi-
tion, the percentage of cell labeling was graded as less than
25% (negative) or greater than or equal to 25% (positive). The
staining intensity of normal breast glands for a given patient
was assessed from sections of margin tissue blocks or from
morphologically identified normal glands within the same slide
containing malignant tumors. Normal mammary glands identi-
fied adjacent to the tumor cells and/or on corresponding mar-
gin tissue sections were analyzed in 18 cases.
Western blot analysis
For tissue samples, frozen tissue (100 mg) was homogenized
in 500 μL of ice-cold radioimmunoprecipitation assay (RIPA)
buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1% NP-40, 1% Tri-
ton X-100, 0.1% SDS, 1% sodium deoxycholate, 1 mM EDTA,
50 mM NaF, 10 mM sodium pyrophosphate, and 0.5 mM DTT)
with freshly added protease inhibitors (Sigma-Aldrich). After a
30-minute incubation on ice, samples were spun at 12,000
rpm for 20 minutes at 4°C and supernatants were collected.
For cultured cells, cells were washed twice with PBS and
lysed with cold RIPA lysis buffer containing protease inhibitors
(PMSF [phenylmethylsulphonyl fluoride] 1 mmol/L and leupep-
tin 0.1 g/L). Cell lysates were collected from culture plates
using a rubber policeman, and protein was collected by cen-
trifugation. Protein concentrations were determined by BCA
(bicinchoninic acid) protein assay (Pierce, Rockford, IL, USA).
Aliquots of 40 μg of proteins were boiled in 2× loading buffer
(0.1 M Tris-Cl, pH 6.8, 4% SDS, 0.2% bromophenyl blue, and
20% glycerol) for 10 minutes, loaded into 10% Tris-HCl poly-
acrylamide gels, and transferred electrophoretically to Immo-
bilon-P membrane (Millipore Corporation, Billerica, MA, USA).
Membranes were incubated with primary antibodies and
appropriate HRP secondary antibodies. Membranes were
additionally probed with an antibody against actin (Santa Cruz
Biotechnology, Inc.) to ensure equal loading of protein
between samples. Detection was performed with chemilumi-
nescent agents (Pierce).
Reverse transcription-polymerase chain reaction 
analysis
Total cellular RNA was extracted with TRIzol Reagent (Invitro-
gen Corporation, Carlsbad, CA, USA) according to the manu-
facturer's instructions. RNA concentration was determined by
measuring UV absorption. The sequence of the polymerase
chain reaction (PCR) primer pairs used for the amplification of
human  derlin-1  was forward 5'-ATGTCGGACATCGGA-
GACTG-3' and reverse 5'-CTGGTCTCCAAGTCGAAAG-3'.
The sequence of the primer pairs used for the amplification of
human glyceraldehyde-3-phosphate dehydrogenase (gapdh)
was forward 5'-GAGTCAACGGATTTGGTCGT-3' and
reverse 5'-GATCTCGCTCCTGGAAGATG-3'. The amplifica-
tion condition for both derlin-1 and gapdh consisted of 25
cycles of 30 seconds at 94°C, 30 seconds at 52°C, and 50
seconds at 72°C. The amplified products were separated by
electrophoresis on a 1% agarose gel, stained with ethidium
bromide, and photographed under UV illumination.
RNA interference
The target sequence used for knockdown of derlin-1 was
TGGATATGCAGTTGCTGAT (347–365). The effectiveness
of oligonucleotides targeting this sequence has been
described [20]. The small interfering RNA (siRNA) against der-
lin-1 and a negative control siRNA were provided by
Guangzhou RiboBio Co., Ltd. (Guangzhou, China). Subcon-
fluent proliferating cells in 12-well plates were incubated with
50 nM siRNA in 2 mL of medium containing Lipofectamine
2000 (Invitrogen Corporation). Seventy-two hours later, total
proteins were extracted from the cells to detect derlin-1 level
by Western blot analysis.
Flow cytometry
Apoptotic cells were determined by propidium iodide staining
and flow cytometry as described [21,22]. Briefly, replicate cul-
tures of 1 × 106 cells were plated in cell culture wells. The cells
were transfected with control siRNA or derlin-1 siRNA. Forty-
eight hours after the transfection, cells were treated with or
without 300 nM TG for 24 hours, followed by harvesting,
washing of cells with PBS, and fixing in 70% ethanol for 30
minutes at 4°C. The fixed cells were treated with 50 μg/mL
RNase A (Sigma-Aldrich) and stained with 50 μg/mL propid-
ium iodide for 20 minutes at 4°C in the dark before flow cyto-
metric analyses. The propidium iodide fluorescence ofBreast Cancer Research    Vol 10 No 1    Wang et al.
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individual nuclei was measured in the red fluorescence using
a flow cytometer (Beckman Coulter Elite; Beckman Coulter,
Fullerton, CA, USA), and the data were registered in a logarith-
mic scale. Apoptotic nuclei appeared as a broad hypodiploid
DNA (sub-G1) peak, which can be distinguished from the
narrow hyperdiploid peak of nuclei. Quantification of apoptotic
cells was carried out by measurement of sub-G1 DNA content.
Statistical analysis
The chi-square test was used to analyze the correlation
between derlin-1 expression on IHC and clinicopathological
features. One-way analysis of variance with the least signifi-
cant difference post hoc test was used to test for the differ-
ences in the means of apoptosis rate. All P values are two-
tailed; P values of less than 0.05 were considered significant.
Results
Derlin-1 is overexpressed in the majority of human 
breast tumors
The pathological diagnosis for all tumors was infiltrating breast
carcinoma, with a tumor grade ranging from I to III. Immunohis-
tochemical analyses were performed in a blinded manner with
respect to the pathology of the tissues being analyzed. The
specificity of the primary antibody against human derlin-1 was
validated. Whereas cytosolic staining was found to be strongly
present in a breast cancer case (Figure 1a), no staining was
detected in sections from the same sample when the section
was subject to immunohistochemical analysis using the anti-
body against derlin-1 that was pre-incubated with peptide anti-
gen (Figure 1b). Derlin-1 signal intensity was graded as none
to weak (that is, negative) or as moderate to strong (that is,
positive) (Figure 1c–f). Of the 42 patients included in this
study, 28 (66.7%) scored positively for expression of derlin-1,
and 10 of these 28 had very strong derlin-1 labeling. With
respect to the number of cells labeled, greater than or equal to
25% labeling was seen in all positive cases. In addition, derlin-
1 expression is predominantly present in the cytosol of tumor
cells, but not in stromal cells.
We also investigated derlin-1 expression in normal mammary
glands. The staining intensity of normal mammary glands adja-
cent to tumor could be evaluated in five sections containing
malignant tumors and normal glands in the same slide.
Whereas no staining for derlin-1 was detected in the normal
mammary glands, a signal of moderate or strong intensity was
detected in all adjacent tumors (Figure 2). In addition, both
IHC and Western blot analysis were employed to evaluate lev-
els of derlin-1 expression in another set of tumor samples with
paired normal breast tissues from 13 patients. Among the 13
cases, only 2 normal breast tissues showed weak expression
of derlin-1, whereas the other 11 normal breast tissues
showed negative expression. However, derlin-1 was charac-
terized by moderate or strong intensity in 8 of 13 paired tumor
samples. A representative Western blot analysis is shown in
Figure 3. Altogether, among the evaluated normal mammary
glands, only 2 of 18 cases showed weak expression of derlin-
1, whereas the others showed negative expression.
Derlin-1 expression correlates with tumor grade and 
lymph node metastasis
For the women diagnosed with breast cancer, we had data for
tumor characteristics and noted no association between age,
tumor size, and derlin-1 expression. Twenty-seven of 42
(64.3%) women had grade 3 tumors. Twenty-one of the grade
3 tumors (77.8%) showed moderate or strong derlin-1 inten-
sity, whereas 7 of 15 grade 1 and grade 2 tumors (46.7%)
were derlin-1-positive. Estrogen receptor, progesterone
receptor, and ErbB-2 status in these tumors were also rou-
tinely detected by IHC. We found no significant association
between derlin-1 expression and estrogen receptor, proges-
terone receptor, and ErbB-2 status, although derlin-1 tends to
be overexpressed more frequently in ErbB-2-positive tumors
(Table 1). In addition, 24 of 42 (57.1%) cases developed axil-
lary lymph node metastasis. Derlin-1 showed moderate or
strong staining in 20 of the 24 (83.3%) node-positive cases.
However, only 8 of 18 (44.4%) node-negative cases showed
Figure 1
Immunohistochemical staining of breast carcinoma with polyclonal anti- body against derlin-1 Immunohistochemical staining of breast carcinoma with polyclonal anti-
body against derlin-1. (a) Positive derlin-1 labeling in a breast cancer 
section. Note that the immunoreactivity was limited to the cytoplasm of 
the neoplastic cells. (b) Negative derlin-1 labeling in the section from 
the same breast cancer tissue block when derlin-1 antibody was pre-
incubated with the corresponding peptide antigen. (c) The absence of 
signal was scored as '0'. (d) Low-intensity signal was scored as '1'. (e) 
Moderate-intensity signal was scored as '2'. (f) High-intensity signal 
was scored as '3'. Bars, 50 μm.Available online http://breast-cancer-research.com/content/10/1/R7
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moderate or strong derlin-1 expression. Derlin-1 expression
significantly correlated with axillary lymph node metastasis of
breast cancer.
Endoplasmic reticulum stress induces derlin-1 
expression in breast cancer cells
Since derlin-1 is frequently overexpressed in breast tumors,
we investigated whether derlin-1 was constitutively overex-
pressed or induced by stress inducers in breast cancer cell
lines. TM and TG can induce ER stress by impairing glycosyla-
tion of newly synthesized proteins and by disrupting Ca2+
homeostasis, respectively. We cultured a panel of human
breast cancer cell lines (T47D, MDA-MB-435, MDA-MB-453,
MCF-7, SKBR-3, and 1590) in the absence of TM and TG.
Whereas a high level of derlin-1 was detected in SKBR-3
cells, derlin-1 expresses at a low level in other non-treated
breast cancer cell lines (Figure 4a). We then treated T47D,
MDA-MB-435, and MD-MBA-453 cells with 2 μg/mL TM and
300 nM TG for 24 hours. TM and TG induced derlin-1 and
GRP78 expression significantly in these cells (Figure 4b). To
investigate whether derlin-1 is induced by TM and TG at the
transcriptional level, total RNA from non-treated or TM- and
TG-treated T47D cells was subjected to reverse transcription-
PCR analysis. Both TM and TG significantly enhanced derlin-
1 expression at the mRNA level (Figure 4c). In addition, nutri-
tion starvation can induce ER stress. Serum starvation signifi-
cantly induced derlin-1 expression in T47D cells (Figure 4c,d).
These data suggest that derlin-1 expression may be induced
by the stress inducers within the tumor microenvironment.
Derlin-1 protects breast cancer cells against 
endoplasmic reticulum stress-induced apoptosis
Persistent or unalleviated ER stress can trigger apoptosis in
mammalian cells. However, cancer cells are relatively resistant
to ER stress-induced apoptosis. To investigate the effect of
derlin-1 on the apotosis-inducing potential of ER stress in
breast cancer cells, derlin-1 siRNA was introduced into
SKBR-3 cells to inhibit the expression of endogenous derlin-1,
followed by flow cytometry analysis of apoptosis in cells
treated with or without 300 nM TG for 24 hours. In contrast to
other breast cancer cell lines included in this study, derlin-1
was constitutively expressed at a high level in SKBR-3 cells,
but treatment with TG did not induce further derlin-1 expres-
sion in this cell line. Treatment with TG did enhance GRP78
expression, demonstrating the effectiveness of this treatment
in UPR induction. The synthetic derlin-1 siRNA (siDerlin-1) sig-
nificantly reduced derlin-1 protein level in both unstressed
cells and TG-treated cells, whereas the control siRNA (siCtrl)
did not affect derlin-1 expression (Figure 5a). In vehicle-
treated cells, there was no significant difference in the apop-
tosis rate between siCtrl-transfected and siDerlin-1-trans-
fected cells. Upon ER stress, the siDerlin-1-transfected cells
showed a significant increase in apoptosis rate compared with
the siCtrl-transfected cells that received TG (Figure 5b). To
demonstrate whether the effects of derlin-1 on cell survival are
Figure 2
Representative immunohistochemical staining for derlin-1 protein in  normal human mammary glands and breast cancer tissues Representative immunohistochemical staining for derlin-1 protein in 
normal human mammary glands and breast cancer tissues. (a) Positive 
derlin-1 expression was detected in the cytoplasm of tumor cells (blue 
arrow) but not in the adjacent mammary epithelial cells (red arrows). (b) 
An enlarged view of the derlin-1-positive tumor cells in (a). (c) An 
enlarged view of the normal mammary epithelial cells in (a). (d) The 
same expression was detected as in (a) but in a different sample con-
taining tumor cells (blue arrow) and mammary epithelial cells (red 
arrow). Bars, 50 μm.
Figure 3
Derlin-1 expression in human breast cancer and paired normal breast  tissue Derlin-1 expression in human breast cancer and paired normal breast 
tissue. A representative Western blot analysis of derlin-1 protein in 
breast carcinoma (T) and paired normal mammary glands (N) from four 
patients is shown. In each line is the expression of actin used as a load-
ing control to normalize the derlin-1 protein levels in each sample.Breast Cancer Research    Vol 10 No 1    Wang et al.
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specific to ER stress or were a general mechanism of stress
resistance, the same cells were treated with 1 μM stau-
rosporine for 24 hours. Downregulation of derlin-1 did not
result in increased sensitivity to staurosporine. Treatment of
cells with this drug did not result in the induction of ER stress
marker GRP78 (Figure 5c). Thus, derlin-1 expression may pro-
tect breast cancer cells against ER stress-induced apoptosis.
These data suggest that derlin-1 represents a prosurvival arm
of the UPR.
Discussion
The increasing importance of adaptation to tumor microenvi-
ronment in cancer progression has led to the development of
novel biomarkers and molecular targets for cancer therapy. It
has been well documented that cytotoxic insults are present in
many cancer cells and the cellular response to resist the per-
sistent stress is often enhanced [23,24]. As the tumor grows,
it experiences increasing nutrient starvation. Cells respond by
producing proangiogenic factors to initiate tumor angiogen-
esis [3,25]. Although tumors secrete angiogenic factors to
promote vasculature growth, this often is not sufficient to pro-
vide optimal oxygen and nutrients to the tumor. To better cope
with the stressful microenvironment, cells might evoke other
cytoprotective responses to make them adapt to the unfavora-
ble conditions, such as ER overload response or UPR [26].
The UPR is a tightly coordinated cellular program characteris-
tic of an increase in the expression of molecular chaperones,
protein folding, and the degradation of terminally misfolded
proteins. So far, it is still unclear how tumor cells adapt to long-
term ER stress in vivo.
Eukaryotic cells express a family of highly conserved proteins
that evoke protective mechanisms against physiological
stresses in the intra- and extra-cellular microenvironments.
This family of stress proteins includes the heat shock proteins
(HSPs) [27] and glucose-regulated proteins (GRPs) [28].
Both HSPs and GRPs are inducible by ER stress factors. Pre-
vious studies from human tumors have demonstrated the acti-
vation of various branches of the UPR in cancer. HSPs and
GRPs are frequently overexpressed in a variety of tumors,
especially in the late stage of disease. The best characterized
of the GRPs is a 78-kDa protein known as GRP78, which is
identical to BiP, the immunoglobulin heavy-chain-binding pro-
tein [29,30]. GRP78 shares similar function and 60% amino
acid homology with HSP70. Distinct from the HSPs, GRPs
are generally non-inducible or only weakly inducible by heat
Table 1
Correlations of derlin-1 immunohistochemistry in human breast carcinomas
Established tumor characteristics Derlin-1 immunohistochemistry P value (chi-square)
Absent to weak Moderate to strong
Tumor size
≤ 2 cm 6 10 NS
>2 cm 8 18
Tumor grade
I and II 8 7 <0.05
III 6 21
Estrogen receptor
Negative 6 13 NS
Positive 8 15
Progesterone receptor
Negative 5 12 NS
Positive 9 16
ErbB-2
Negative 10 13 NS
Positive 4 15
Lymph node metastasis
Absent 10 8 <0.01
Present 4 20
NS, not significant.Available online http://breast-cancer-research.com/content/10/1/R7
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[31]. GRP78 functions as an ER-resident molecular chaper-
one, which has been reported to be overexpressed more
frequently in the higher-grade breast tumors than in lower-
grade tumors [13]. Furthermore, X-box binding protein 1
(XBP-1), a transcription factor that regulates unfolded protein/
ER stress response, is frequently overexpressed in many
breast tumors, but hardly detectable in non-cancerous breast
tissues [32].
Recently, another ER-resident protein, derlin-1, was identified
to be involved in ER stress response. Derlin-1 seems to be a
multifunctional protein, which participates in the dislocation of
misfolded proteins from the ER and mediates the retrotranslo-
cation of proteins from ER lumen into the cytosol [18,19]. Der-
lin-1 reportedly carries four transmembrane domains, with
both N-terminus and C-terminus within the cytosol. Derlin-1
depletion in Caenorhabditis elegans results in ER stress [19]
and its expression is upregulated by inducers of ER stress in
yeast [33] and C. elegans [19]. Our study is the first to exam-
ine the expression of derlin-1 in human cancer. Of the breast
carcinomas, 28 of 42 (66.7%) expressed moderate to high
levels of derlin-1, whereas derlin-1 rarely expressed in normal
mammary epithelial cells. These data demonstrate that the
levels of derlin-1 protein were elevated in the majority of the
malignant human breast tumors compared with normal mam-
mary glands. Notably, derlin-1 expression was more strongly
present in higher-grade breast carcinomas than in lower-grade
tumors, suggesting that derlin-1 expression may correlate with
a more malignant phenotype. The full induction of derlin-1
expression in mouse embryonic fibroblasts in response to ER
stress is dependent on the IRE1-XBP-1 pathway [20]. A pre-
vious study has demonstrated that XBP-1 is upregulated in
human breast cancer [32]. In view of this, our data relate to
previous findings by demonstrating that derlin-1, one part of
the ERAD machinery and an effecter downstream of XBP-1, is
frequently overexpressed in breast cancer.
Figure 4
Analysis of derlin-1 expression in human breast cancer cell lines Analysis of derlin-1 expression in human breast cancer cell lines. (a) 
Western blot analysis of derlin-1 protein in T47D, MDA-MB-453, MCF-
7, SKBR-3, MDA-MB-435, and 1590 cells. (b) Western blot analysis of 
derlin-1 protein in T47D, MDA-MB-453, and MDA-MB-435 cells that 
were exposed to 2 μg/mL tunicamycin (TM) and 300 nM thapsigargin 
(TG) for 24 hours. (c) Reverse transcription-polymerase chain reaction 
analysis of derlin-1 expression in T47D cells that were exposed to TM, 
TG, and serum starvation. (d) Western blot analysis of derlin-1 protein 
in T47D cells that were exposed to serum starvation. GAPDH, glyceral-
dehyde-3-phosphate dehydrogenase.
Figure 5
Effects of derlin-1 knockdown on endoplasmic reticulum stress- induced apoptosis Effects of derlin-1 knockdown on endoplasmic reticulum stress-
induced apoptosis. (a) Western blot analysis of derlin-1 and GRP78 in 
non-treated or thapsigargin (TG)-treated SKBR-3 cells that were trans-
fected with or without small interfering RNA (siRNA). (b) The percent-
age of apoptosis in non-treated, TG-treated, and staurosporine-treated 
SKBR-3 cells that were transfected with siCtrl or siDerlin-1. Columns 
indicate the mean of three experiments; bars indicate the standard 
error. (c) Western blot analysis of GRP78 in vehicle-treated, stau-
rosporine-treated, and thapsigargin-treated cells. siCtrl, control small 
interfering RNA; siDerlin-1, derlin-1 small interfering RNA.Breast Cancer Research    Vol 10 No 1    Wang et al.
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In the present study, we demonstrated a significant associa-
tion between derlin-1 expression and axillary lymph node
metastasis, suggesting that derlin-1 may be involved in the
aggressive tumor growth or metastasis. Metastasis consists of
a series of sequential steps, all of which have to be accom-
plished. These include detachment of cells from a primary
tumor, survival of cancer cells in the circulation, and arrest in
the secondary sites [34]. It is well known that apoptosis is a
rate-limiting process in the tumor metastasis cascade. This
study demonstrated that derlin-1 could protect cancer cells
against ER stress-induced apoptosis, which might confer met-
astatic properties to cancer cells. Additionally, derlin-1 expres-
sion may protect cancer cells from stresses encountered
during tumor growth. Although lymph node metastasis is an
indicator of poor prognosis of patients with breast carcinomas
[35], a long-term follow-up is warranted to clarify whether
derlin-1 expression is associated with the outcome in breast
cancer, especially in lymph node-negative breast cancer. Inter-
estingly, VCP, a partner of derlin-1 in the retrotranslocation
complex, was overexpressed in colorectal carcinomas. The
VCP expression level is an independent prognosticator for
recurrence of colorectal carcinoma and patient survival [17].
Also, previous studies have demonstrated that other stress-
responsive proteins, which are regulated by different branches
of the UPR, are frequently overexpressed in certain types of
tumors. In light of the molecular heterogeneity of cancer cells,
these findings indicate that a broad transcriptional program
induced during the UPR might be more relevant to cancer than
the simple expression of one of these stress-responsive pro-
teins. Thus, stress proteins may prove to be valuable tumor
markers and possible therapeutic targets.
Conclusion
In summary, this study demonstrated that derlin-1 expression
is not constitutively overexpressed in some breast cancer cell
lines but can be significantly induced by serum starvation and
agents that disturb ER function. These data suggest that der-
lin-1 expression might be induced by the ER stress that is
present in breast cancer. Furthermore, this study demon-
strated that derlin-1 knockdown in breast cancer cells
rendered cancer cells more susceptible to ER stress-induced
apoptosis, indicating that derlin-1 overexpression in breast
cancer may enhance cancer cell survival following exposure to
stress. Overall, these findings reveal the involvement of derlin-
1, a critical part of the UPR, in tumorigenesis via increased
expression and the capability of relieving stress-induced
apoptosis.
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